Pharma Journalist -

Immune Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to bertilimumab for the treatment of bullous pemphigoid (BP).…
Read More...

The Centre for the Commercialization of Antibodies and Biologics (CCAB) and ImmunoBiochem Corporation have announced an agreement that will see CCAB provide a new investment to help…
Read More...

Enigma Biomedical Group (EBG) announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug…
Read More...

Healthcare supply chain has become extremely complex as a business activity due to increasing competition, changing regulations and rising costs and unique because each stakeholder has…
Read More...

SMi Reports: This year’s Immuno-Oncology Conference Chair James Legg, Vice President R&D at Crescendo Biologics, has released a letter of invitation detailing this year’s event.…
Read More...

An exclusive interview with Dr. Yanming Zu, Director at Abon Pharmaceuticals has been released SMi Reports: An exclusive interview with Dr. Yanming Zu, Director at Abon…
Read More...

Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. announced positive topline results from a Phase 3, randomized, double-blind, placebo-controlled study of…
Read More...

Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration (FDA).…
Read More...

Eisai Inc. and Merck, known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA …
Read More...

BioNTech AG announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. to develop mRNA-based vaccines for prevention of influenza…
Read More...